OptimizeRx announces multi-year agreement with leading hub services provider

OptimizeRx announced a multi-million-dollar, three-year agreement with a leading Hub services company that will leverage OptimizeRx technology to accelerate patient access for its life sciences brands through digitization of disparate processes. The patient services provider will license the electronic Hub technology which was introduced to the OptimizeRx suite of solutions through the EvinceMed acquisition in 2022. The engagement is focused on determining drug eligibility and affordability and will help accelerate access to coverage and affordability information for pharma-sponsored patient support programs. "Given the steady increase in new specialty medications hitting the market, coupled with increasing digitization of market access strategies, our Hub Services counterparts are looking for ways to increase the volume of patients they can handle more efficiently," said OptimizeRx Chief Commercial Officer Steve Silvestro. "Our interests are aligned with our Hub colleagues to hasten time to therapy for patients, and this represents a new facet to our market opportunity within market access for life sciences brands."